Trial Profile

G-Pen (Glucagon Injection) for Induced Hypoglycemia Rescue in Adult Patients With T1D

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Glucagon (Primary)
Indications Hypoglycaemia
Focus Therapeutic Use
Sponsors XERIS Pharmaceuticals

Most Recent Events

15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
16 Jun 2017 According to a Xeris Pharmaceuticals media release, results were presented at the 77th Scientific Session of the American Diabetes Association (ADA)
16 Jun 2017 Results published in a Xeris Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com